Skip to main content

Search This Blog

Pulmonary Hypertension

Posts

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines | Circulation

Get link
Facebook
X
Pinterest
Email
Other Apps

February 20, 2026

Invalid Access Key! Invalid Access Key!

Right-sided heart failure in acute respiratory distress syndrome - ERS

Get link
Facebook
X
Pinterest
Email
Other Apps

February 20, 2026

Invalid Access Key! Invalid Access Key!

Pulmonary valve stenosis - Symptoms & causes

Get link
Facebook
X
Pinterest
Email
Other Apps

February 20, 2026

Invalid Access Key! Invalid Access Key!

Cardiovascular diseases (CVDs)

Get link
Facebook
X
Pinterest
Email
Other Apps

February 20, 2026

Invalid Access Key! Invalid Access Key!

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

Get link
Facebook
X
Pinterest
Email
Other Apps

February 20, 2026

Invalid Access Key! Invalid Access Key!

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

Get link
Facebook
X
Pinterest
Email
Other Apps

February 18, 2026

Invalid Access Key! Invalid Access Key!

Cardiovascular diseases (CVDs)

Get link
Facebook
X
Pinterest
Email
Other Apps

February 18, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by 4x6

Archive

February45
January81
December24
November48
October76
September59
August77
July70
June61
May79

Show more Show less

Popular posts from this blog

Pulmonary Hypertension

Pulmonary Hypertension Living Well with Pulmonary Hypertension? Yes We Can! (A Rehab Specialist’s Advice) - Pulmonary Hypertension News Unexpected Life Lessons from My Hospital Roommate - Pulmonary Hypertension News Doctors Urge Early Diagnosis to Save Lives in PH, Other Rare Diseases - Pulmonary Hypertension News Living Well with Pulmonary Hypertension? Yes We Can! (A Rehab Specialist’s Advice) - Pulmonary Hypertension News Posted: 01 Mar 2019 12:37 AM PST Hello, World! For those of you who don't know me, my name is Noah Greenspan. I am the founder and program director of the Pulmonary Wellness & Rehabilitation Center in New York City. I am also the founder of the Ultimate Pulmonary Wellness Webinar Series , the Ultimate Pulmonary Wellness Facebook Group , the Pulmonary Wellness Research and Education Society , author of Ultimate Pulmonary Wellness , and creator of Pulmonary Welln...

Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech

Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech Altavant nabs Boehringer, Gilead alum as new CMO - FierceBiotech Posted: 02 Mar 2020 12:00 AM PST While no longer a member of Vivek Ramaswamy's Roivant umbrella group, his former Vant company is still able to bring in the big names. Altavant, which saw its stake recently sold off alongside a host of other 'Vants' by Ramaswamy to a subsidiary of Japanese pharma Sumitomo Dainippon Pharma, is working on a series of clinical assets for respiratory diseases. The Vant name has long drawn big names from biopharma (though they have not always stuck around for long ), but despite having a new parent, Altavant still has the pulling power to nab Howard Lazarus, M.D., as it CMO. Sponsored by Clinical Ink Successful BYOD in Any Phase This white paper discusses BYOD advantages and misconceptions, regulatory, copyright, and equivalency considerations, and a Ph...

FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News

September 11, 2019

FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News FDA Names SoniVie's TIVUS System a Breakthrough Device for PAH - Pulmonary Hypertension News Posted: 11 Sep 2019 05:00 AM PDT The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to SoniVie's Therapeutic Intra-Vascular Ultrasound (TIVUS) System for the treatment of people with pulmonary arterial hypertension (PAH). Similar to breakthrough therapy , the designation of breakthrough device is given to medical equipment that provides significant advantages over currently available options. It is intended to accelerate the development, review, and approval of devices that have been designed to treat irreversibly debilitating or life-threatening conditions. "There are no approved medical device treatment options for PAH, only medications. The TIVUS Sy...

Labels

"pulmonary hypertension prognosis" - Google News
idiopathic pulmonary hypertension
IFTTT
mild pulmonary hypertension
pulmonary artery hypertension
Pulmonary Hypertension
pulmonary hypertension causes
pulmonary hypertension diagnosis
pulmonary hypertension medications
pulmonary hypertension prognosis

pulmonary hypertension symptoms
pulmonary hypertension treatment
severe pulmonary hypertension
what is pulmonary hypertension

Show more Show less

yand